An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1

Acetyl-CoA carboxylase (ACC) catalyzes the conversion of acetyl-CoA to malonyl-CoA, the first committed step in de novo fatty acid synthesis. Although the enzyme is activated in response to insulin, the mechanism of activation is unclear. In adipose tissue, ACC is phosphorylated on a distinct sit...

Full description

Bibliographic Details
Main Author: Collins, Susan Elizabeth
Format: Others
Language:English
Published: 2009
Online Access:http://hdl.handle.net/2429/11510
id ndltd-UBC-oai-circle.library.ubc.ca-2429-11510
record_format oai_dc
spelling ndltd-UBC-oai-circle.library.ubc.ca-2429-115102018-01-05T17:35:56Z An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1 Collins, Susan Elizabeth Acetyl-CoA carboxylase (ACC) catalyzes the conversion of acetyl-CoA to malonyl-CoA, the first committed step in de novo fatty acid synthesis. Although the enzyme is activated in response to insulin, the mechanism of activation is unclear. In adipose tissue, ACC is phosphorylated on a distinct site, the ‘I-site’, in a PI3K-dependent manner following insulin stimulation but the kinase responsible has not yet been identified. This thesis describes work done to test the role of the atypical PKC isozymes as potential ACC kinases. Analysis of kinase expression revealed that PKC isozymes delta, zeta, and mu (PKD) were highly expressed in rat white adipose tissue. Of nine purified PKC isozymes tested in vitro, PKC-zeta phosporylated ACC most efficiently, but the stoichiometry of phosphorylation was still very low. In adipocytes, the PKC inhibitor Ro 31-8220 accelerated the activation of ACC in response to insulin, suggesting that a target of the compound is normally involved in the inhibition of ACC activation. Another PKC inhibitor, Go 6983, had no effect. The two compounds have similar potency against PKC isozymes, with the exception of PKC-betal and -betall which are more sensitive to Ro 31-8220. AMPK, which has been reported to inhibit ACC in adipose tissue, is also inhibited by Ro 31-8220 in vitro, but probably not in adipocytes. This indicates that some kinase other than AMPK is responsible for inhibition of ACC in adipocytes. The delay in ACC activation following insulin stimulation may represent an important control in glucose utilization. In addition, the more rapid activation of ACC following treatment of adipocytes with Ro 31-8220 indicates that a target of this compound is responsible for the delay. Medicine, Faculty of Biochemistry and Molecular Biology, Department of Graduate 2009-07-30T19:04:53Z 2009-07-30T19:04:53Z 2001 2001-05 Text Thesis/Dissertation http://hdl.handle.net/2429/11510 eng For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use. 6453793 bytes application/pdf
collection NDLTD
language English
format Others
sources NDLTD
description Acetyl-CoA carboxylase (ACC) catalyzes the conversion of acetyl-CoA to malonyl-CoA, the first committed step in de novo fatty acid synthesis. Although the enzyme is activated in response to insulin, the mechanism of activation is unclear. In adipose tissue, ACC is phosphorylated on a distinct site, the ‘I-site’, in a PI3K-dependent manner following insulin stimulation but the kinase responsible has not yet been identified. This thesis describes work done to test the role of the atypical PKC isozymes as potential ACC kinases. Analysis of kinase expression revealed that PKC isozymes delta, zeta, and mu (PKD) were highly expressed in rat white adipose tissue. Of nine purified PKC isozymes tested in vitro, PKC-zeta phosporylated ACC most efficiently, but the stoichiometry of phosphorylation was still very low. In adipocytes, the PKC inhibitor Ro 31-8220 accelerated the activation of ACC in response to insulin, suggesting that a target of the compound is normally involved in the inhibition of ACC activation. Another PKC inhibitor, Go 6983, had no effect. The two compounds have similar potency against PKC isozymes, with the exception of PKC-betal and -betall which are more sensitive to Ro 31-8220. AMPK, which has been reported to inhibit ACC in adipose tissue, is also inhibited by Ro 31-8220 in vitro, but probably not in adipocytes. This indicates that some kinase other than AMPK is responsible for inhibition of ACC in adipocytes. The delay in ACC activation following insulin stimulation may represent an important control in glucose utilization. In addition, the more rapid activation of ACC following treatment of adipocytes with Ro 31-8220 indicates that a target of this compound is responsible for the delay. === Medicine, Faculty of === Biochemistry and Molecular Biology, Department of === Graduate
author Collins, Susan Elizabeth
spellingShingle Collins, Susan Elizabeth
An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1
author_facet Collins, Susan Elizabeth
author_sort Collins, Susan Elizabeth
title An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1
title_short An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1
title_full An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1
title_fullStr An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1
title_full_unstemmed An investigation of the potential role of PKC isoforms in the regulation of acetyl-CoA carboxylase-1
title_sort investigation of the potential role of pkc isoforms in the regulation of acetyl-coa carboxylase-1
publishDate 2009
url http://hdl.handle.net/2429/11510
work_keys_str_mv AT collinssusanelizabeth aninvestigationofthepotentialroleofpkcisoformsintheregulationofacetylcoacarboxylase1
AT collinssusanelizabeth investigationofthepotentialroleofpkcisoformsintheregulationofacetylcoacarboxylase1
_version_ 1718588880107601920